Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mazure, N. M.
Right arrow Articles by Giaccia, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mazure, N. M.
Right arrow Articles by Giaccia, A. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

RAPID COMMUNICATION


Induction of Vascular Endothelial Growth Factor by Hypoxia Is Modulated by a Phosphatidylinositol 3-Kinase/Akt Signaling Pathway in Ha-ras-Transformed Cells Through a Hypoxia Inducible Factor-1 Transcriptional Element

Nathalie M. Mazure, Eunice Y. Chen, Keith R. Laderoute, and Amato J. Giaccia

From the Mayer Cancer Biology Research Laboratory, the Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA; and SRI International Pharmaceutical Discovery Division, Menlo Park, CA.

Tumor angiogenesis, the development of new blood vessels, is a highly regulated process that is controlled genetically by alterations in oncogene and tumor suppressor gene expression and physiologically by the tumor microenvironment. Previous studies indicate that the angiogenic switch in Ras-transformed cells may be physiologically promoted by the tumor microenvironment through the induction of the angiogenic mitogen, vascular endothelial growth factor (VEGF). In this report, we show Ras-transformed cells do not use the downstream effectors c-Raf-1 or mitogen activated protein kinases (MAPK) in signaling VEGF induction by hypoxia as overexpression of kinase-defective alleles of these genes does not inhibit VEGF induction under low oxygen conditions. In contrast to the c-Raf-1/MAP kinase pathway, hypoxia increases phosphatidylinositol 3-kinase (PI 3-kinase) activity in a Ras-dependent manner, and inhibition of PI 3-kinase activity genetically and pharmacologically results in inhibition of VEGF induction. We propose that hypoxia modulates VEGF induction in Ras-transformed cells through the activation of a stress inducible PI 3-kinase/Akt pathway and the hypoxia inducible factor-1 (HIF-1) transcriptional response element.

Blood, Vol. 90 No. 9 (November 1), 1997: pp. 3322-3331
© 1997 by The American Society of Hematology.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
M. Yoshie, E. Miyajima, S. Kyo, and K. Tamura
Stathmin, a Microtubule Regulatory Protein, Is Associated with Hypoxia-Inducible Factor-1{alpha} Levels in Human Endometrial and Endothelial Cells
Endocrinology, May 1, 2009; 150(5): 2413 - 2418.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Pencreach, E. Guerin, C. Nicolet, I. Lelong-Rebel, A.-C. Voegeli, P. Oudet, A. K. Larsen, M.-P. Gaub, and D. Guenot
Marked Activity of Irinotecan and Rapamycin Combination toward Colon Cancer Cells In vivo and In vitro Is Mediated through Cooperative Modulation of the Mammalian Target of Rapamycin/Hypoxia-Inducible Factor-1{alpha} Axis
Clin. Cancer Res., February 15, 2009; 15(4): 1297 - 1307.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
E. Letavernier, P. Bruneval, S. Vandermeersch, J. Perez, C. Mandet, M.-F. Belair, J.-p. Haymann, C. Legendre, and L. Baud
Sirolimus interacts with pathways essential for podocyte integrity
Nephrol. Dial. Transplant., February 1, 2009; 24(2): 630 - 638.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. P. Yun, M. Y. Lee, J. M. Ryu, C. H. Song, and H. J. Han
Role of HIF-1{alpha} and VEGF in human mesenchymal stem cell proliferation by 17{beta}-estradiol: involvement of PKC, PI3K/Akt, and MAPKs
Am J Physiol Cell Physiol, February 1, 2009; 296(2): C317 - C326.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Ader, L. Brizuela, P. Bouquerel, B. Malavaud, and O. Cuvillier
Sphingosine Kinase 1: A New Modulator of Hypoxia Inducible Factor 1{alpha} during Hypoxia in Human Cancer Cells
Cancer Res., October 15, 2008; 68(20): 8635 - 8642.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. G. Van den Eynden, M. Smid, S. J. Van Laere, C. G. Colpaert, I. Van der Auwera, T. X. Bich, P. van Dam, M. A. den Bakker, L. Y. Dirix, E. A. Van Marck, et al.
Gene Expression Profiles Associated with the Presence of a Fibrotic Focus and the Growth Pattern in Lymph Node-Negative Breast Cancer
Clin. Cancer Res., May 15, 2008; 14(10): 2944 - 2952.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. J. Wang, S. X. Zhang, R. Mott, Y. Chen, R. R. Knapp, W. Cao, and J.-x. Ma
Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy
Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1166 - F1173.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S.-N. Jung, W. K. Yang, J. Kim, H. S. Kim, E. J. Kim, H. Yun, H. Park, S. S. Kim, W. Choe, I. Kang, et al.
Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells
Carcinogenesis, April 1, 2008; 29(4): 713 - 721.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. Toral-Barza, W.-G. Zhang, X. Huang, L. A. McDonald, E. J. Salaski, L. R. Barbieri, W.-D. Ding, G. Krishnamurthy, Y. B. Hu, J. Lucas, et al.
Discovery of lactoquinomycin and related pyranonaphthoquinones as potent and allosteric inhibitors of AKT/PKB: mechanistic involvement of AKT catalytic activation loop cysteines
Mol. Cancer Ther., November 1, 2007; 6(11): 3028 - 3038.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Q. Zhang, X. Tang, Z.-F. Zhang, R. Velikina, S. Shi, and A. D. Le
Nicotine Induces Hypoxia-Inducible Factor-1{alpha} Expression in Human Lung Cancer Cells via Nicotinic Acetylcholine Receptor Mediated Signaling Pathways
Clin. Cancer Res., August 15, 2007; 13(16): 4686 - 4694.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. Flugel, A. Gorlach, C. Michiels, and T. Kietzmann
Glycogen Synthase Kinase 3 Phosphorylates Hypoxia-Inducible Factor 1{alpha} and Mediates Its Destabilization in a VHL-Independent Manner
Mol. Cell. Biol., May 1, 2007; 27(9): 3253 - 3265.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X. Tang, Q. Zhang, J. Nishitani, J. Brown, S. Shi, and A. D. Le
Overexpression of Human Papillomavirus Type 16 Oncoproteins Enhances Hypoxia-Inducible Factor 1{alpha} Protein Accumulation and Vascular Endothelial Growth Factor Expression in Human Cervical Carcinoma Cells
Clin. Cancer Res., May 1, 2007; 13(9): 2568 - 2576.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
B. Bedogni, S. M. Welford, A. C. Kwan, J. Ranger-Moore, K. Saboda, and M. B. Powell
Inhibition of phosphatidylinositol-3-kinase and mitogen-activated protein kinase kinase 1/2 prevents melanoma development and promotes melanoma regression in the transgenic TPRas mouse model
Mol. Cancer Ther., December 1, 2006; 5(12): 3071 - 3077.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Nie, S. Krishnamoorthy, R. Jin, K. Tang, Y. Chen, Y. Qiao, A. Zacharek, Y. Guo, J. Milanini, G. Pages, et al.
Mechanisms Regulating Tumor Angiogenesis by 12-Lipoxygenase in Prostate Cancer Cells
J. Biol. Chem., July 7, 2006; 281(27): 18601 - 18609.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
N. Pore, Z. Jiang, H.-K. Shu, E. Bernhard, G. D. Kao, and A. Maity
Akt1 Activation Can Augment Hypoxia-Inducible Factor-1{alpha} Expression by Increasing Protein Translation through a Mammalian Target of Rapamycin-Independent Pathway
Mol. Cancer Res., July 1, 2006; 4(7): 471 - 479.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A R L Medford and A B Millar
Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?
Thorax, July 1, 2006; 61(7): 621 - 626.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
C. Koumenis and B. G. Wouters
"Translating" Tumor Hypoxia: Unfolded Protein Response (UPR)-Dependent and UPR-Independent Pathways
Mol. Cancer Res., July 1, 2006; 4(7): 423 - 436.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Tan, L. Geng, E. M. Yazlovitskaya, and D. E. Hallahan
Protein Kinase B/Akt-Dependent Phosphorylation of Glycogen Synthase Kinase-3{beta} in Irradiated Vascular Endothelium
Cancer Res., February 15, 2006; 66(4): 2320 - 2327.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
F. Kaper, N. Dornhoefer, and A. J. Giaccia
Mutations in the PI3K/PTEN/TSC2 Pathway Contribute to Mammalian Target of Rapamycin Activity and Increased Translation under Hypoxic Conditions
Cancer Res., February 1, 2006; 66(3): 1561 - 1569.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. T. Dang, F. Chen, L. B. Gardner, J. M. Cummins, C. Rago, F. Bunz, S. V. Kantsevoy, and L. H. Dang
Hypoxia-Inducible Factor-1{alpha} Promotes Nonhypoxia-Mediated Proliferation in Colon Cancer Cells and Xenografts
Cancer Res., February 1, 2006; 66(3): 1684 - 1693.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. W.J. van der Schaft, F. Hillen, P. Pauwels, D. A. Kirschmann, K. Castermans, M. G.A. oude Egbrink, M. G.B. Tran, R. Sciot, E. Hauben, P. C.W. Hogendoorn, et al.
Tumor Cell Plasticity in Ewing Sarcoma, an Alternative Circulatory System Stimulated by Hypoxia
Cancer Res., December 15, 2005; 65(24): 11520 - 11528.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Parsons
Phosphatidylinositol 3-Kinase Inhibitors Are a Triple Threat to Ovarian Cancer
Clin. Cancer Res., November 15, 2005; 11(22): 7965 - 7966.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Hu, J. Hofmann, and R. B. Jaffe
Phosphatidylinostol 3-Kinase Mediates Angiogenesis and Vascular Permeability Associated with Ovarian Carcinoma
Clin. Cancer Res., November 15, 2005; 11(22): 8208 - 8212.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
D. Trisciuoglio, A. Iervolino, G. Zupi, and D. Del Bufalo
Involvement of PI3K and MAPK Signaling in bcl-2-induced Vascular Endothelial Growth Factor Expression in Melanoma Cells
Mol. Biol. Cell, September 1, 2005; 16(9): 4153 - 4162.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Zhou, S. Lechpammer, J. S. Greenberger, and J. Glowacki
Hypoxia Inhibition of Adipocytogenesis in Human Bone Marrow Stromal Cells Requires Transforming Growth Factor-{beta}/Smad3 Signaling
J. Biol. Chem., June 17, 2005; 280(24): 22688 - 22696.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. Treins, S. Giorgetti-Peraldi, J. Murdaca, M.-N. Monthouel-Kartmann, and E. Van Obberghen
Regulation of Hypoxia-Inducible Factor (HIF)-1 Activity and Expression of HIF Hydroxylases in Response to Insulin-Like Growth Factor I
Mol. Endocrinol., May 1, 2005; 19(5): 1304 - 1317.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Blum, J. Jacob-Hirsch, N. Amariglio, G. Rechavi, and Y. Kloog
Ras Inhibition in Glioblastoma Down-regulates Hypoxia-Inducible Factor-1{alpha}, Causing Glycolysis Shutdown and Cell Death
Cancer Res., February 1, 2005; 65(3): 999 - 1006.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
E. V. Gerasimovskaya, D. A. Tucker, and K. R. Stenmark
Activation of phosphatidylinositol 3-kinase, Akt, and mammalian target of rapamycin is necessary for hypoxia-induced pulmonary artery adventitial fibroblast proliferation
J Appl Physiol, February 1, 2005; 98(2): 722 - 731.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Frantz, K. A. Vincent, O. Feron, and R. A. Kelly
Innate Immunity and Angiogenesis
Circ. Res., January 7, 2005; 96(1): 15 - 26.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Q. Liu, U. Moller, D. Flugel, and T. Kietzmann
Induction of plasminogen activator inhibitor I gene expression by intracellular calcium via hypoxia-inducible factor-1
Blood, December 15, 2004; 104(13): 3993 - 4001.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. Hoeben, B. Landuyt, M. S. Highley, H. Wildiers, A. T. Van Oosterom, and E. A. De Bruijn
Vascular Endothelial Growth Factor and Angiogenesis
Pharmacol. Rev., December 1, 2004; 56(4): 549 - 580.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Giatromanolaki, M. I. Koukourakis, C. Simopoulos, A. Polychronidis, K. C. Gatter, A. L. Harris, and E. Sivridis
c-erbB-2 Related Aggressiveness in Breast Cancer Is Hypoxia Inducible Factor-1{alpha} Dependent
Clin. Cancer Res., December 1, 2004; 10(23): 7972 - 7977.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
X. Zhang, T. Kon, H. Wang, F. Li, Q. Huang, Z. N. Rabbani, J. P. Kirkpatrick, Z. Vujaskovic, M. W. Dewhirst, and C.-Y. Li
Enhancement of Hypoxia-Induced Tumor Cell Death In vitro and Radiation Therapy In vivo by Use of Small Interfering RNA Targeted to Hypoxia-Inducible Factor-1{alpha}
Cancer Res., November 15, 2004; 64(22): 8139 - 8142.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
N. Pore, S. Liu, H.-K. Shu, B. Li, D. Haas-Kogan, D. Stokoe, J. Milanini-Mongiat, G. Pages, D. M. O'Rourke, E. Bernhard, et al.
Sp1 Is Involved in Akt-mediated Induction of VEGF Expression through an HIF-1-independent Mechanism
Mol. Biol. Cell, November 1, 2004; 15(11): 4841 - 4853.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Segrelles, S. Ruiz, M. Santos, J. Martinez-Palacio, M. F. Lara, and J. M. Paramio
Akt mediates an angiogenic switch in transformed keratinocytes
Carcinogenesis, July 1, 2004; 25(7): 1137 - 1147.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
O. Stoeltzing, M. F. McCarty, J. S. Wey, F. Fan, W. Liu, A. Belcheva, C. D. Bucana, G. L. Semenza, and L. M. Ellis
Role of Hypoxia-Inducible Factor 1{alpha} in Gastric Cancer Cell Growth, Angiogenesis, and Vessel Maturation
J Natl Cancer Inst, June 16, 2004; 96(12): 946 - 956.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Bedogni, M. S. O'Neill, S. M. Welford, D. M. Bouley, A. J. Giaccia, N. C. Denko, and M. B. Powell
Topical Treatment with Inhibitors of the Phosphatidylinositol 3'-Kinase/Akt and Raf/Mitogen-Activated Protein Kinase Kinase/Extracellular Signal-Regulated Kinase Pathways Reduces Melanoma Development in Severe Combined Immunodeficient Mice
Cancer Res., April 1, 2004; 64(7): 2552 - 2560.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Hopfl, O. Ogunshola, and M. Gassmann
HIFs and tumors--causes and consequences
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R608 - R623.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C.-H. Chung, W.-B. Wu, and T.-F. Huang
Aggretin, a snake venom-derived endothelial integrin {alpha}2{beta}1 agonist, induces angiogenesis via expression of vascular endothelial growth factor
Blood, March 15, 2004; 103(6): 2105 - 2113.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Mizukami, J. Li, X. Zhang, M. A. Zimmer, O. Iliopoulos, and D. C. Chung
Hypoxia-Inducible Factor-1-Independent Regulation of Vascular Endothelial Growth Factor by Hypoxia in Colon Cancer
Cancer Res., March 1, 2004; 64(5): 1765 - 1772.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Neid, K. Datta, S. Stephan, I. Khanna, S. Pal, L. Shaw, M. White, and D. Mukhopadhyay
Role of Insulin Receptor Substrates and Protein Kinase C-{zeta} in Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression in Pancreatic Cancer Cells
J. Biol. Chem., February 6, 2004; 279(6): 3941 - 3948.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Xu, P. S. Pathak, and D. Fukumura
Hypoxia-Induced Activation of p38 Mitogen-Activated Protein Kinase and Phosphatidylinositol 3'-Kinase Signaling Pathways Contributes to Expression of Interleukin 8 in Human Ovarian Carcinoma Cells
Clin. Cancer Res., January 15, 2004; 10(2): 701 - 707.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Delmas, D. End, P. Rochaix, G. Favre, C. Toulas, and E. Cohen-Jonathan
The Farnesyltransferase Inhibitor R115777 Reduces Hypoxia and Matrix Metalloproteinase 2 Expression in Human Glioma Xenograft
Clin. Cancer Res., December 1, 2003; 9(16): 6062 - 6068.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Wu, A. P. Mannam, J. Wu, S. Kirbis, J.-L. Shie, C. Chen, R. J. Laham, F. W. Sellke, and J. Li
Hypoxia induces myocyte-dependent COX-2 regulation in endothelial cells: role of VEGF
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2420 - H2429.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. E. Lancet and J. E. Karp
Farnesyltransferase inhibitors in hematologic malignancies: new horizons in therapy
Blood, December 1, 2003; 102(12): 3880 - 3889.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-G. Yoo, S. H. Oh, E. S. Park, H. Cho, N. Lee, H. Park, D. K. Kim, D.-Y. Yu, J. K. Seong, and M.-O. Lee
Hepatitis B Virus X Protein Enhances Transcriptional Activity of Hypoxia-inducible Factor-1{alpha} through Activation of Mitogen-activated Protein Kinase Pathway
J. Biol. Chem., October 3, 2003; 278(40): 39076 - 39084.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Mottet, V. Dumont, Y. Deccache, C. Demazy, N. Ninane, M. Raes, and C. Michiels
Regulation of Hypoxia-inducible Factor-1{alpha} Protein Level during Hypoxic Conditions by the Phosphatidylinositol 3-Kinase/Akt/Glycogen Synthase Kinase 3{beta} Pathway in HepG2 Cells
J. Biol. Chem., August 15, 2003; 278(33): 31277 - 31285.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. T.-L. Tang and L. A. Lasky
The Forkhead Transcription Factor FOXO4 Induces the Down-regulation of Hypoxia-inducible Factor 1{alpha} by a von Hippel-Lindau Protein-independent Mechanism
J. Biol. Chem., August 8, 2003; 278(32): 30125 - 30135.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
D. C. Lev, M. Ruiz, L. Mills, E. C. McGary, J. E. Price, and M. Bar-Eli
Dacarbazine Causes Transcriptional Up-Regulation of Interleukin 8 and Vascular Endothelial Growth Factor in Melanoma Cells: A Possible Escape Mechanism from Chemotherapy
Mol. Cancer Ther., August 1, 2003; 2(8): 753 - 763.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Zhang, N. Yang, D. Katsaros, W. Huang, J.-W. Park, S. Fracchioli, C. Vezzani, I. A. Rigault de la Longrais, W. Yao, S. C. Rubin, et al.
The Oncogene Phosphatidylinositol 3'-Kinase Catalytic Subunit {alpha} Promotes Angiogenesis via Vascular Endothelial Growth Factor in Ovarian Carcinoma
Cancer Res., July 15, 2003; 63(14): 4225 - 4231.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
N. J. Mabjeesh, M. T. Willard, C. E. Frederickson, H. Zhong, and J. W. Simons
Androgens Stimulate Hypoxia-inducible Factor 1 Activation via Autocrine Loop of Tyrosine Kinase Receptor/Phosphatidylinositol 3'-Kinase/Protein Kinase B in Prostate Cancer Cells
Clin. Cancer Res., July 1, 2003; 9(7): 2416 - 2425.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
P. Wachsberger, R. Burd, and A. P. Dicker
Tumor Response to Ionizing Radiation Combined with Antiangiogenesis or Vascular Targeting Agents: Exploring Mechanisms of Interaction
Clin. Cancer Res., June 1, 2003; 9(6): 1957 - 1971.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Abe, K. Terada, H. Wakimoto, R. Inoue, E. Tyminski, R. Bookstein, J. P. Basilion, and E. A. Chiocca
PTEN Decreases in Vivo Vascularization of Experimental Gliomas in Spite of Proangiogenic Stimuli
Cancer Res., May 1, 2003; 63(9): 2300 - 2305.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Fukuda, B. Kelly, and G. L. Semenza
Vascular Endothelial Growth Factor Gene Expression in Colon Cancer Cells Exposed to Prostaglandin E2 Is Mediated by Hypoxia-inducible Factor 1
Cancer Res., May 1, 2003; 63(9): 2330 - 2334.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
B. Krishnamachary, S. Berg-Dixon, B. Kelly, F. Agani, D. Feldser, G. Ferreira, N. Iyer, J. LaRusch, B. Pak, P. Taghavi, et al.
Regulation of Colon Carcinoma Cell Invasion by Hypoxia-Inducible Factor 1
Cancer Res., March 1, 2003; 63(5): 1138 - 1143.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. Ahmad, A. Ahmad, E. Gerasimovskaya, K. R. Stenmark, C. B. Allen, and C. W. White
Hypoxia Protects Human Lung Microvascular Endothelial and Epithelial-like Cells against Oxygen Toxicity: Role of Phosphatidylinositol 3-Kinase
Am. J. Respir. Cell Mol. Biol., February 1, 2003; 28(2): 179 - 187.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Kietzmann, A. Samoylenko, U. Roth, and K. Jungermann
Hypoxia-inducible factor-1 and hypoxia response elements mediate the induction of plasminogen activator inhibitor-1 gene expression by insulin in primary rat hepatocytes
Blood, February 1, 2003; 101(3): 907 - 914.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
K. Reisinger, R. Kaufmann, and J. Gille
Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription
J. Cell Sci., January 15, 2003; 116(2): 225 - 238.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Pore, S. Liu, D. A. Haas-Kogan, D. M. O'Rourke, and A. Maity
PTEN Mutation and Epidermal Growth Factor Receptor Activation Regulate Vascular Endothelial Growth Factor (VEGF) mRNA Expression in Human Glioblastoma Cells by Transactivating the Proximal VEGF Promoter
Cancer Res., January 1, 2003; 63(1): 236 - 241.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. S. Eshleman, B. L. Carlson, A. C. Mladek, B. D. Kastner, K. L. Shide, and J. N. Sarkaria
Inhibition of the Mammalian Target of Rapamycin Sensitizes U87 Xenografts to Fractionated Radiation Therapy
Cancer Res., December 15, 2002; 62(24): 7291 - 7297.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. H. Liu, A. Kirschenbaum, M. Lu, S. Yao, A. Dosoretz, J. F. Holland, and A. C. Levine
Prostaglandin E2 Induces Hypoxia-inducible Factor-1alpha Stabilization and Nuclear Localization in a Human Prostate Cancer Cell Line
J. Biol. Chem., December 13, 2002; 277(51): 50081 - 50086.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Gao, B.-H. Jiang, S. S. Leonard, L. Corum, Z. Zhang, J. R. Roberts, J. Antonini, J. Z. Zheng, D. C. Flynn, V. Castranova, et al.
p38 Signaling-mediated Hypoxia-inducible Factor 1alpha and Vascular Endothelial Growth Factor Induction by Cr(VI) in DU145 Human Prostate Carcinoma Cells
J. Biol. Chem., November 15, 2002; 277(47): 45041 - 45048.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Karni, Y. Dor, E. Keshet, O. Meyuhas, and A. Levitzki
Activated pp60c-Src Leads to Elevated Hypoxia-inducible Factor (HIF)-1alpha Expression under Normoxia
J. Biol. Chem., November 1, 2002; 277(45): 42919 - 42925.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. C. Hudson, M. Liu, G. G. Chiang, D. M. Otterness, D. C. Loomis, F. Kaper, A. J. Giaccia, and R. T. Abraham
Regulation of Hypoxia-Inducible Factor 1{alpha} Expression and Function by the Mammalian Target of Rapamycin
Mol. Cell. Biol., October 15, 2002; 22(20): 7004 - 7014.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. A. Chan, P. D. Sutphin, N. C. Denko, and A. J. Giaccia
Role of Prolyl Hydroxylation in Oncogenically Stabilized Hypoxia-inducible Factor-1alpha
J. Biol. Chem., October 11, 2002; 277(42): 40112 - 40117.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
S. A. Woods, C. J. McGlade, and A. Guha
Phosphatidylinositol 3'-kinase and MAPK/ERK kinase 1/2 differentially regulate expression of vascular endothelial growth factor in human malignant astrocytoma cells
Neuro-oncol, October 1, 2002; 4(4): 242 - 252.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
N. Gao, M. Ding, J. Z. Zheng, Z. Zhang, S. S. Leonard, K. J. Liu, X. Shi, and B.-H. Jiang
Vanadate-induced Expression of Hypoxia-inducible Factor 1alpha and Vascular Endothelial Growth Factor through Phosphatidylinositol 3-Kinase/Akt Pathway and Reactive Oxygen Species
J. Biol. Chem., August 23, 2002; 277(35): 31963 - 31971.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
K. A. Seta, Z. Spicer, Y. Yuan, G. Lu, and D. E. Millhorn
Responding to Hypoxia: Lessons From a Model Cell Line
Sci. Signal., August 20, 2002; 2002(146): re11 - re11.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Rapisarda, B. Uranchimeg, D. A. Scudiero, M. Selby, E. A. Sausville, R. H. Shoemaker, and G. Melillo
Identification of Small Molecule Inhibitors of Hypoxia-inducible Factor 1 Transcriptional Activation Pathway
Cancer Res., August 1, 2002; 62(15): 4316 - 4324.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Kaluz, M. Kaluzova, A. Chrastina, P. L. Olive, S. Pastorekova, J. Pastorek, M. I. Lerman, and E. J. Stanbridge
Lowered Oxygen Tension Induces Expression of the Hypoxia Marker MN/Carbonic Anhydrase IX in the Absence of Hypoxia-inducible Factor 1{alpha} Stabilization: A Role for Phosphatidylinositol 3'-Kinase
Cancer Res., August 1, 2002; 62(15): 4469 - 4477.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Takahashi, Y. Kureishi, J. Yang, Z. Luo, K. Guo, D. Mukhopadhyay, Y. Ivashchenko, D. Branellec, and K. Walsh
Myogenic Akt Signaling Regulates Blood Vessel Recruitment during Myofiber Growth
Mol. Cell. Biol., July 1, 2002; 22(13): 4803 - 4814.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. HUMAR, F. N. KIEFER, H. BERNS, T. J. RESINK, and E. J. BATTEGAY
Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR) -dependent signaling
FASEB J, June 1, 2002; 16(8): 771 - 780.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Arsham, D. R. Plas, C. B. Thompson, and M. C. Simon
Phosphatidylinositol 3-Kinase/Akt Signaling Is Neither Required for Hypoxic Stabilization of HIF-1alpha nor Sufficient for HIF-1-dependent Target Gene Transcription
J. Biol. Chem., April 19, 2002; 277(17): 15162 - 15170.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Alvarez-Tejado, A. Alfranca, J. Aragones, A. Vara, M. O. Landazuri, and L. del Peso
Lack of Evidence for the Involvement of the Phosphoinositide 3-Kinase/Akt Pathway in the Activation of Hypoxia-inducible Factors by Low Oxygen Tension
J. Biol. Chem., April 12, 2002; 277(16): 13508 - 13517.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Xu, D. Fukumura, and R. K. Jain
Acidic Extracellular pH Induces Vascular Endothelial Growth Factor (VEGF) in Human Glioblastoma Cells via ERK1/2 MAPK Signaling Pathway. MECHANISM OF LOW pH-INDUCED VEGF
J. Biol. Chem., March 22, 2002; 277(13): 11368 - 11374.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. J. Mick, X. Wang, and K. McCormick
White Adipocyte Vascular Endothelial Growth Factor: Regulation by Insulin
Endocrinology, March 1, 2002; 143(3): 948 - 953.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. S. McClintock, M. T. Santore, V. Y. Lee, J. Brunelle, G. R. S. Budinger, W.-X. Zong, C. B. Thompson, N. Hay, and N. S. Chandel
Bcl-2 Family Members and Functional Electron Transport Chain Regulate Oxygen Deprivation-Induced Cell Death
Mol. Cell. Biol., January 1, 2002; 22(1): 94 - 104.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
J.N. UPALAKALIN, I. HEMO, C. DEHIO, E. KESHET, and L.E. BENJAMIN
Survival Mechanisms of VEGF and PlGF during Microvascular Remodeling
Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 181 - 188.
[Abstract] [PDF]


Home page
Cancer Res.Home page
A. Tenzer, D. Zingg, S. Rocha, B. Hemmings, D. Fabbro, C. Glanzmann, P. A. Schubiger, S. Bodis, and M. Pruschy
The Phosphatidylinositide 3'-Kinase/Akt Survival Pathway Is a Target for the Anticancer and Radiosensitizing Agent PKC412, an Inhibitor of Protein Kinase C
Cancer Res., November 1, 2001; 61(22): 8203 - 8210.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Blancher, J. W. Moore, N. Robertson, and A. L. Harris
Effects of ras and von Hippel-Lindau (VHL) Gene Mutations on Hypoxia-inducible Factor (HIF)-1{alpha}, HIF-2{alpha}, and Vascular Endothelial Growth Factor Expression and Their Regulation by the Phosphatidylinositol 3'-Kinase/Akt Signaling Pathway
Cancer Res., October 1, 2001; 61(19): 7349 - 7355.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Sonoda, T. Ozawa, K. D. Aldape, D. F. Deen, M. S. Berger, and R. O. Pieper
Akt Pathway Activation Converts Anaplastic Astrocytoma to Glioblastoma Multiforme in a Human Astrocyte Model of Glioma
Cancer Res., September 1, 2001; 61(18): 6674 - 6678.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Oettgen
Transcriptional Regulation of Vascular Development
Circ. Res., August 31, 2001; 89(5): 380 - 388.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. Dong, Z. Chen, Z.-Y. Li, N. T. Yeh, C. C. Bancroft, and C. Van Waes
Hepatocyte Growth Factor/Scatter Factor-induced Activation of MEK and PI3K Signal Pathways Contributes to Expression of Proangiogenic Cytokines Interleukin-8 and Vascular Endothelial Growth Factor in Head and Neck Squamous Cell Carcinoma
Cancer Res., August 1, 2001; 61(15): 5911 - 5918.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. M. Popovici, M. Lu, S. Bhatia, G. H. Faessen, A. J. Giaccia, and L. C. Giudice
Hypoxia Regulates Insulin-Like Growth Factor-Binding Protein 1 in Human Fetal Hepatocytes in Primary Culture: Suggestive Molecular Mechanisms for in Utero Fetal Growth Restriction Caused by Uteroplacental Insufficiency
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2653 - 2659.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
Y.-L. Hu, M.-K. Tee, E. J. Goetzl, N. Auersperg, G. B. Mills, N. Ferrara, and R. B. Jaffe
Lysophosphatidic Acid Induction of Vascular Endothelial Growth Factor Expression in Human Ovarian Cancer Cells
J Natl Cancer Inst, May 16, 2001; 93(10): 762 - 767.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Jones, C. Fujiyama, C. Blanche, J. W. Moore, S. Fuggle, D. Cranston, R. Bicknell, and Adrian. L. Harris
Relation of Vascular Endothelial Growth Factor Production to Expression and Regulation of Hypoxia-inducible Factor-1{{alpha}} and Hypoxia-inducible Factor-2{{alpha}} in Human Bladder Tumors and Cell Lines
Clin. Cancer Res., May 1, 2001; 7(5): 1263 - 1272.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. Kosmidou, A. Xagorari, C. Roussos, and A. Papapetropoulos
Reactive oxygen species stimulate VEGF production from C2C12 skeletal myotubes through a PI3K/Akt pathway
Am J Physiol Lung Cell Mol Physiol, April 1, 2001; 280(4): L585 - L592.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Y. Chen, N. M. Mazure, J. A. Cooper, and A. J. Giaccia
Hypoxia Activates a Platelet-derived Growth Factor Receptor/Phosphatidylinositol 3-Kinase/Akt Pathway That Results in Glycogen Synthase Kinase-3 Inactivation
Cancer Res., March 1, 2001; 61(6): 2429 - 2433.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
R. Bos, H. Zhong, C. F. Hanrahan, E. C. M. Mommers, G. L. Semenza, H. M. Pinedo, M. D. Abeloff, J. W. Simons, P. J. van Diest, and E. van der Wall
Levels of Hypoxia-Inducible Factor-1{{alpha}} During Breast Carcinogenesis
J Natl Cancer Inst, February 21, 2001; 93(4): 309 - 314.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. Chen, A. T. Treweeke, D. C. West, K. J. Till, J. C. Cawley, M. Zuzel, and C. H. Toh
In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cells
Blood, November 1, 2000; 96(9): 3181 - 3187.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Dimmeler and A. M. Zeiher
Endothelial Cell Apoptosis in Angiogenesis and Vessel Regression
Circ. Res., September 15, 2000; 87(6): 434 - 439.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Sodhi, S. Montaner, V. Patel, M. Zohar, C. Bais, E. A. Mesri, and J. S. Gutkind
The Kaposi's Sarcoma-associated Herpes Virus G Protein-coupled Receptor Up-Regulates Vascular Endothelial Growth Factor Expression and Secretion through Mitogen-activated Protein Kinase and p38 Pathways Acting on Hypoxia-inducible Factor 1{{alpha}}
Cancer Res., September 1, 2000; 60(17): 4873 - 4880.
[Abstract] [Full Text]


Home page
Genes Dev.Home page
G. L. Semenza
HIF-1 and human disease: one highly involved factor
Genes & Dev., August 15, 2000; 14(16): 1983 - 1991.
[Full Text]


Home page
JNCI J Natl Cancer InstHome page
L. M. Ellis and G. E. Gallick
Promiscuous Transcription of Vascular Endothelial Growth Factor and Survival of Tumors
J Natl Cancer Inst, July 5, 2000; 92(13): 1030 - 1031.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Inoue, J. W. Slaton, D. W. Davis, D. J. Hicklin, D. J. McConkey, T. Karashima, R. Radinsky, and C. P. N. Dinney
Treatment of Human Metastatic Transitional Cell Carcinoma of the Bladder in a Murine Model with the Anti-Vascular Endothelial Growth Factor Receptor Monoclonal Antibody DC101 and Paclitaxel
Clin. Cancer Res., July 1, 2000; 6(7): 2635 - 2643.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
K. R. Laderoute, R. M. Alarcon, M. D. Brody, J. M. Calaoagan, E. Y. Chen, A. M. Knapp, Z. Yun, N. C. Denko, and A. J. Giaccia
Opposing Effects of Hypoxia on Expression of the Angiogenic Inhibitor Thrombospondin 1 and the Angiogenic Inducer Vascular Endothelial Growth Factor
Clin. Cancer Res., July 1, 2000; 6(7): 2941 - 2950.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. M. Fredriksson, J. M. Lindquist, G. E. Bronnikov, and J. Nedergaard
Norepinephrine Induces Vascular Endothelial Growth Factor Gene Expression in Brown Adipocytes through a beta -Adrenoreceptor/cAMP/Protein Kinase A Pathway Involving Src but Independently of Erk1/2
J. Biol. Chem., April 28, 2000; 275(18): 13802 - 13811.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. Zundel, L. M. Swiersz, and A. Giaccia
Caveolin 1-Mediated Regulation of Receptor Tyrosine Kinase-Associated Phosphatidylinositol 3-Kinase Activity by Ceramide
Mol. Cell. Biol., March 1, 2000; 20(5): 1507 - 1514.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
H. Zhong, K. Chiles, D. Feldser, E. Laughner, C. Hanrahan, M.-M. Georgescu, J. W. Simons, and G. L. Semenza
Modulation of Hypoxia-inducible Factor 1{{alpha}} Expression by the Epidermal Growth Factor/Phosphatidylinositol 3-Kinase/PTEN/AKT/FRAP Pathway in Human Prostate Cancer Cells: Implications for Tumor Angiogenesis and Therapeutics
Cancer Res., March 1, 2000; 60(6): 1541 - 1545.
[Abstract] [Full Text]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1997 by American Society of Hematology         Online ISSN: 1528-0020